Whitehawk Therapeutics Stock (NASDAQ:WHWK)

Revenue Financials Chart Transcripts

Previous Close

$1.79

52W Range

$1.39 - $3.81

50D Avg

$1.82

200D Avg

$2.13

Market Cap

$94.73M

Avg Vol (3M)

$116.91K

Beta

0.64

Div Yield

-

WHWK Company Profile

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

40

IPO Date

Aug 01, 2017

Website

WHWK Performance

WHWK Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	$25.98M	$24.35M	$15.22M
Operating Income	$-67.46M	$-71.93M	$-62.68M
Net Income	$-63.69M	$-65.77M	$-60.51M
EBITDA	$-64.63M	$-71.76M	$-58.80M
Basic EPS	$-2.36	$-2.44	$-2.69
Diluted EPS	$-2.36	$-2.44	$-2.69

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts

Q4 24Mar 19, 25 | 8:30 AM

Q2 24Aug 10, 24 | 8:30 AM

Q1 24May 08, 24 | 8:30 AM